Physician profile
Robert W Phillips
NPI 1689664625
$1,562.80
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,015 · 2020: $500 · 2021: $33.82 · 2022: $14.28.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $745.07 | 2019 | |
| Stryker Corporation | $500.00 | 2020 | |
| Boston Scientific Corporation | $136.22 | 2019-2022 | |
| Intuitive Surgical, INC. | $40.00 | 2019 | |
| Daiichi Sankyo INC. | $34.59 | 2019 | |
| Amag Pharmaceuticals, INC. | $26.65 | 2019 | |
| Minerva Surgical, INC | $19.68 | 2021 | |
| Abbvie INC. | $18.02 | 2019 | |
| Merck Sharp & Dohme LLC | $15.17 | 2019 | |
| Hologic Sales and Service, LLC | $14.14 | 2021 | |
| Lupin INC. | $13.26 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.